| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 10/01/2009 | US20090246190 Monoclonal antibody that binds human vascular endothelial grwoth factor; can be used to treat edema and other unwanted cell proliferation |
| 10/01/2009 | US20090246180 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 10/01/2009 | US20090246173 Treatment with anti-vegf antibodies |
| 10/01/2009 | US20090246132 Epitope bound by MAbs A, B, C or D, where MAbs A, B, C and D have given variable domains; chimeric or humanized for side effect reduction; polymerase chain reaction |
| 10/01/2009 | US20090246131 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies |
| 10/01/2009 | US20090246129 Compositions and methods for the diagnosis and treatment of tumor |
| 10/01/2009 | DE102008016064A1 Verfahren zur Diagnose und Behandlung von chronisch psychiatrischen Erkrankungen sowie Marker und Targets für solche Verfahren A process for diagnosis and treatment of psychiatric disorders and chronic markers and targets for such methods |
| 10/01/2009 | CA2719761A1 Glucagon receptor antagonists |
| 10/01/2009 | CA2719553A1 Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof |
| 10/01/2009 | CA2719201A1 Neutralizing molecules to viral antigens |
| 10/01/2009 | CA2719041A1 Compositions, methods, and kits |
| 10/01/2009 | CA2718321A1 Human anti-mesothelin monoclonal antibodies |
| 10/01/2009 | CA2717905A1 Methods and compositions for treating bone loss |
| 10/01/2009 | CA2716884A1 Use of a type ii anti-cd20 antibody with increased antibody dependent cellular cytotoxicity (adcc) in combination with cyclophosphamide, vincristine and doxorubicine for treating non-hodgkin's lymphomas |
| 10/01/2009 | CA2716882A1 Compositions and methods for inhibiting pdgfrbeta and vegf-a |
| 10/01/2009 | CA2712535A1 An anti-cancer cytotoxic monoclonal antibody |
| 09/30/2009 | EP2105504A2 Genes and proteins, and their use |
| 09/30/2009 | EP2105502A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/30/2009 | EP2105449A2 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 09/30/2009 | EP2105448A2 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine |
| 09/30/2009 | EP2105447A1 Avian-derived antibody capable of binding specifically to human hmgb1, immunological determination method for human hmgb1, and immunological determination reagent for human hmgb1 |
| 09/30/2009 | EP2105446A2 Cytokine receptor zalpha11 |
| 09/30/2009 | EP2104732A1 Cancerous disease modifying antibodies |
| 09/30/2009 | EP2104513A2 Ovr110 antibody compositions and methods of use |
| 09/30/2009 | EP1678308B1 Expression vector for secreting antibody fragment using e. coli signal sequence and method for mass-producing antibody fragment |
| 09/30/2009 | EP1572971B1 Methods of generating high-production of antibodies from hybridomas created by in vitro immunization |
| 09/30/2009 | EP1507859B1 Fusion proteins of humanized g250 specific antibodies and uses thereof |
| 09/30/2009 | EP1465928B1 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies |
| 09/30/2009 | EP1309627B1 Immunotherapy for chronic myelocytic leukemia with naked anti-nca-90 antibody |
| 09/30/2009 | EP1242122B1 Delivery of proteins across polar epithelial cell layers |
| 09/30/2009 | EP1240325B1 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
| 09/30/2009 | EP1185655B1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf) |
| 09/30/2009 | EP1141297B1 Interleukin-17 related mammalian cytokines. polynucleotides encoding them . uses |
| 09/30/2009 | CN101547937A Anti-cancer antibodies against Lewisy and Lewisb antigens |
| 09/30/2009 | CN101547936A Cancerous disease modifying antibodies |
| 09/30/2009 | CN101544965A Coproduction process for extracting various bioactivators from pig placenta |
| 09/30/2009 | CN101544962A EV virus wide spectrum monoclonal antibody and its uses |
| 09/30/2009 | CN101544695A Humanized anti-CD25 single-chain antibody and preparation method |
| 09/30/2009 | CN101544694A Anti-CD20 tetravalent antibody and preparation method and application thereof |
| 09/30/2009 | CN101544689A Leptospira vaccine candidate outer membrane protein |
| 09/30/2009 | CN101543513A Method using coupling of probiotic bacteria and virus for producing medicine |
| 09/30/2009 | CN100545261C Novel phospholipases and uses thereof |
| 09/30/2009 | CN100545174C Compositions and methods for wt1 specific immunotherapy |
| 09/29/2009 | US7595380 Monoclonal antibodies and methods for their use in the detection of cervical disease |
| 09/29/2009 | US7595379 Monoclonal antibody comprising an antigen binding site that binds specifically to PSCA protein wherein monoclonal antibody comprises the amino acid sequence of the variable heavy chain region and the variable light chain region of antibody secreted by hybridoma assigned A.T.C.C. Accession No.: PTA-6697 |
| 09/29/2009 | US7595378 Can be produced by a transfectoma or in a non-human transgenic animal |
| 09/29/2009 | US7595298 Ala-Arg-Nal-Cys-Tyr-Arg-Lys-DLys-Pro-Tyr-Arg-Cit-Cys-Arg; viricide; low cytotoxicity |
| 09/29/2009 | US7595294 Pituitary adenylate cyclase activating peptide; solid phase synthesis; diabetes, insulin resistance, metabolic acidosis and obesity |
| 09/29/2009 | US7595166 Methods of screening modulators of T2R taste receptors |
| 09/29/2009 | US7595059 Diagnosis of cysticercosis; immunoassay |
| 09/29/2009 | US7595058 Chlamydia antigens and vaccine uses of the protein |
| 09/29/2009 | US7595052 Composition and method for the prevention and/or the treatment of allergy |
| 09/29/2009 | US7595051 Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies |
| 09/29/2009 | US7595050 Human IGM monoclonal antibody capable of inducing apoptosis in HIV-infected cells |
| 09/29/2009 | US7595049 Monoclonal antibody for prevention and treatment of human immunodeficiency viral infection; immunotherapy |
| 09/29/2009 | US7595048 Method for treatment of cancer by inhibiting the immunosuppressive signal induced by PD-1 |
| 09/29/2009 | US7595047 Compositions and methods for promoting or inhibiting angiogenesis |
| 09/29/2009 | US7595046 non-small cell lung, colon, colorectal, lymphoma, pancreatic or ovarian cancer |
| 09/29/2009 | US7595045 Heterodimeric integral membrane glycoprotein specific monoclonal antibody for use in treatment of cancer, inflammatory and/or autoimmune disease |
| 09/29/2009 | US7595044 Artery-and vein-specific proteins and uses therefor |
| 09/29/2009 | CA2250118C Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer |
| 09/29/2009 | CA2240737C A long qt syndrome gene which encodes kvlqt1 and its association with mink |
| 09/29/2009 | CA2194660C Growth differentiation factor-11 |
| 09/29/2009 | CA1341598C Acid-labile sub-unit (als) of insulin-like growth factor binding proteincomplex |
| 09/24/2009 | WO2009117640A2 Antibodies against interleukin-10 like cytokines and uses therefor |
| 09/24/2009 | WO2009117481A1 Use of protease-activated receptor 2 antagonists |
| 09/24/2009 | WO2009117096A1 Methods and agents for the diagnosis and treatment of hepatocellular carcinoma |
| 09/24/2009 | WO2009117085A1 Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase |
| 09/24/2009 | WO2009117035A1 Soluble forms of hendra and nipah virus f glycoprotein and uses thereof |
| 09/24/2009 | WO2009116670A1 Anti-human dlk-1 antibody having anti-tumor activity in vivo |
| 09/24/2009 | WO2009116659A1 Method for detection of liver cancer cell using anti-glypican-3 antibody |
| 09/24/2009 | WO2009116491A1 Monoclonal antibody specifically recognizing human interferon alpha subtype alpha-8 and mutant protein thereof |
| 09/24/2009 | WO2009116268A1 Method for quantification of soluble lr11 |
| 09/24/2009 | WO2009115972A1 Monoclonal antibodies capable of reacting with a plurality of influenza virus a subtypes |
| 09/24/2009 | WO2009115756A2 Method for direct detection of ischaemia-modified albumin using a partner for binding to an aldehyde derivative resulting from the peroxidation of lipids in bound form |
| 09/24/2009 | WO2009115612A1 Biomarkers for rheumatoid arthritis |
| 09/24/2009 | WO2009115508A2 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
| 09/24/2009 | WO2009091826A9 Compositions and methods related to a human cd19-specific chimeric antigen receptor (h-car) |
| 09/24/2009 | WO2009089062A3 Cadherin-11 ecl domain antagonists for treating inflammatory joint disorders |
| 09/24/2009 | WO2009088924A3 Methods and materials for targeted affinity enhancement |
| 09/24/2009 | WO2009073631A3 Antibodies to the pcrv antigen of pseudomonas aeruginosa |
| 09/24/2009 | WO2008036688A3 Optimized antibodies that target hm1.24 |
| 09/24/2009 | WO2004045516A9 Compositions and methods for the diagnosis and treatment of tumor |
| 09/24/2009 | US20090241202 Domain-grafted antibodies |
| 09/24/2009 | US20090240073 Method for detoxifying phosphonate herbicides |
| 09/24/2009 | US20090240039 Polypeptide fusion |
| 09/24/2009 | US20090240038 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 09/24/2009 | US20090240037 Humanized antibodies and methods of humanizing antibodies |
| 09/24/2009 | US20090240036 specifically bind to the p19 subunit of Interleukin-23; high affinity, neutralizing antibodies useful for the treatment of autoimmune disease |
| 09/24/2009 | US20090239793 Polynucleotides and polypeptides associated with trophoblast cell death, differentiation, invasion, and/or cell fusion and turnover |
| 09/24/2009 | US20090239296 for modifying glycans; treating or alleviating a symptom of an immune disorder, tissue injury or cancer |
| 09/24/2009 | US20090239263 Expression Control Using Antibody Expression Optimisation Sequences |
| 09/24/2009 | US20090239246 Biomarkers |
| 09/24/2009 | US20090239236 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy |
| 09/24/2009 | US20090239220 Dlc-1 gene deleted in cancers |
| 09/24/2009 | US20090239216 Novel Tannase Gene And Protein Thereof |
| 09/24/2009 | US20090238886 Retro-Inversion Peptides That Target GIT Transport Receptors and Related Methods |
| 09/24/2009 | US20090238838 Insulinotropic peptide conjugate using an immunoglobulin fc |
| 09/24/2009 | US20090238835 Therapeutic use of anti-cs1 antibodies |
| 09/24/2009 | US20090238834 Identification of protein associated with hepatocellular carcinoma, glioblastoma and lung cancer |